Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis

Israel Journal of Health Policy Research

Volumn 2, Issue 1, 2013, Pages

  Ginsberg, Gary M ^a   Eidelman, Arthur I ^b   Shinwell, Eric ^c   Anis, Emilia ^d   Peyser, Reuven ^e   Lotan, Yoram ^a  

^a MINISTRY OF HEALTH   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

^c KAPLAN HOSPITAL   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cost utility analysis; Group B streptococcal disease; Intrapartum antiobiotic prophyhlaxis; Screening

Indexed keywords

PENICILLIN G;

ANAPHYLACTIC SHOCK; ARTICLE; COST UTILITY ANALYSIS; FEMALE; GESTATIONAL AGE; GROUP B STREPTOCOCCAL MENINGITIS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; INCIDENCE; ISRAEL; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); NEUROLOGIC DISEASE; NEWBORN SEPSIS; PREGNANT WOMAN; PRENATAL DIAGNOSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS AGALACTIAE;

EID: 84883507434     PISSN: None     EISSN: 20454015     Source Type: Journal    
DOI: 10.1186/2045-4015-2-6     Document Type: Article

References (46)

1. German L, Solt I, Bornstein J, Ben-Harush S, Ben-Elishai M, Weintraub Z. Is there an increase in the incidence of gbs carrier rates among pregnant women in northern Israel?. Harefuah 2006, 145(12):866-9. 944. [Article in Hebrew].
2. Eisenberg VH, Raveh D, Meislish Y, Rudensky B, Ezra Y, Samueloff A, Eidelman AI, Schimmel MS. Prevention of early-onset neonatal group B streptococcal infection: is universal screening by culture universally applicable?. Isr Med Assoc J 2006, 10:698-702.
3. Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR 2010, 59:RR-10. 1-25.
4. Ezra Y. Israel perinatal statistics 2008, Sheraton City Towers, Ramat Gan, Israel: Israel Society Maternal -Fetal Medicine.
5. Ministry of Health Health in Israel, selected data 2010 2010, Jerusalem: Health Information Department, Ministry of Health, Ministry of Health.
6. Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal group B streptococcal colonization (review). The Cochrane library, issue 3. CD007467. 2009,
7. Petri W. Penicillins, cephalosporins and other B-lactam antibiotics. Goodman & Gilman's the pharmacological basis of therapeutics 2006, New York, NY: McGraw-Hill, Brunton L, Lazo J, Parker K, 1111th edition.
8. Petitti DB. Overview of methods, decision analysis. Meta analysis, decision analysis, and cost-effectiveness analysis 1994, 20-31. Oxford, England: Oxford University Press.
9. Central Bureau of Statistics Annual abstract of statistics 2010 2011, Jerusalem: CBS, Central Bureau of Statistics.
10. Edwards MS, Rench MA, Haffar AA, et al. Long-term Sequelae of group B streptococcal meningitis in infants. J Pediatr 1985, 106(5):717-722. 10.1016/S0022-3476(85)80342-5, 3889248.
11. Chin KC, Fitzhardinge PM. Sequelae of early-onset group B hemolytic streptococcal neonatal meningitis. J Pediatr 1985, 106(5):819-822. 10.1016/S0022-3476(85)80365-6, 3889251.
12. Horn KA, Zimmerman RA, Knotsman LD, Meyer WT. Neurological sequelae of group B streptococcal neonatal infection. Pediatrics 1974, 53(4):501-504.
13. Wald ER, Bergman I, Taylor HG, Chiponis D, Porter C, Kubek K. Long-term outcome of group B streptococcal meningitis. Pediatrics 1986, 77:217-221.
14. Wald E, Bergman I, Chiponis D, Kubek K. Long-term outcome of group B streptococcal meningitis. Pediatr Res 1984, 18:166A.
15. Baker CJ, Edwards MS. Group B streptococcal infections. Infectious diseases of the fetus and newborn infant 1983, 850. Philadelphia: WB Saunders, Remington JS, Klein JO.
16. Barton LL, Feigin RD, Lins R. Group B beta-hemolytic streptococcal meningitis in infants. J Pediatr 1973, 82:719-723. 10.1016/S0022-3476(73)80605-5, 4572748.
17. Haslam RHA, Allen JR, Dorsen MM, Kanofsky DL, Mellitus ED, Norris DA. The sequelae of group B beta-hemolyte streptococcal meningitis in early infancy. Am J Dis Child 1977, 131:845-849.
18. Bedford H, de Louvois J, Halket S, Peckham C, Hurley R, Harvey D. Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ 2001, 323:1-5. 10.1136/bmj.323.7303.1, 1120656, 11440920.
19. Libster R, Edwards KM, Levent F, Edwards MS, Rench MA, Castagnini LA, Cooper T, Sparks RC, Baker CJ, Shah PE. Pediatrics 2012, 130:e8-e15. Originally published online June 11, 2012, 10.1542/peds.2011-3453, 22689869.
20. Mohle-Boetani C, Schucat A, Phkaytis D, Smith JD, Broome CV. Comparison of prevention strategies for neonatal group B streptococcal infection: a population based economic analysis. JAMA 1993, 270(12):1442-1448. 10.1001/jama.1993.03510120064032, 8371444.
21. Schroeder E-A, Petron S, Balfour G, Edamma O, Heath PT. On behalf of the health protection agency group B streptococcus working group. The economic costs of group B streptococcus (GBS) disease: prospective cohort study of infants with GBS disease in England. Eur J Health Econ 2009, 10(3):275-285. 10.1007/s10198-008-0131-4, 19002511.
22. Ministry of Health Ambulatory and hospitalization price data. July 1st 2009 http://www.health.gov.il/taarifon/file_new/01072009/m010709abc.xls (2009). Accessed 21 October 2010, Ministry of Health.
23. Merrick J. National Survey 2005 on medical services for persons with intellectual disability in residential care in Israel. Int J Disabil Hum Dev 2009, 8:277-282.
24. Talmor D, Greenberg D, Howell MD, Lisbon A, Novack V, Shapiro N. The costs and cost-effectiveness of an integrated sepsis treatment protocol. Crit Care Med 2008, 36(4):1168-1174. 10.1097/CCM.0b013e318168f649, 18379243.
25. WHO The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020 1996, USA: World Health Organization, Murray CJL, Lopez AD, WHO.
26. Bonsel GJ, Genke RJBJ. Health utilities index-Dutch version 1996, Amsterdam: AMC, Department of Clinical Epidemiology and Biostatistics.
27. Feeny D, Furlong W, Boyle M, Torrance GW. Multi-attribute health status classification systems. Health utilities index. PharmacoEconomics 1995, 7(6):490-502. 10.2165/00019053-199507060-00004, 10155335.
28. Torrance GW, Furlong W, Feeny D, Boyle M. Multi-attribute health status preference functions. Health Utilities Index. PharmacoEconomics 1995, 7(6):503-520. 10.2165/00019053-199507060-00005, 10155336.
29. The Netherlands perinatal registry Dutch obstetrics registration 2003, Bilthoven: The Netherlands Perinatal Registry, The Netherlands perinatal registry.
30. Trijbels-Smeulders M, Gerards LJ, Pieternel CM, de Jong P, van Lingen RA, Adriaanse AH, de Jonge GA, Kollée LA. Epidemiology of neonatal group B streptococcal disease in The Netherlands 1997-98. Paediatr Perinat Epidemiol 2002, 16(4):334-341. 10.1046/j.1365-3016.2002.00437.x, 12445150.
31. WHO Commission on MacroEconomics and Health Macroeconomics and health: investing in health for economic development. Report of the commission on macroeconomics and health 2001, Geneva: World Health Organization, WHO Commission on MacroEconomics and Health.
32. Sinha A, Lieu TA, Paoletti LC, Weinstein MC, Platt R. The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. Vaccine 2007, 23:3187-3195.
33. Johannes CB, Ziyadah N, Seeger JD, Tucker E, Reiter C, Faich G. Incidence of Allergic Reactions associated with Antibacterial use in a large, managed care organization. Drug Saf 2007, 30:705-713. 10.2165/00002018-200730080-00007, 17696583.
34. Colbourn TE, Bojke L, Phillips Z, Welton NJ, Claxon K, Ades AE, Gilbert RE. Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and value of information analyses. BMJ 2007, 335(7621):655. Epub 2007 Sep 11. Review 2007, 10.1136/bmj.39325.681806.AD, 1995477, 17848402.
35. Van den Akker-Van Marle ME, Rijnders MEB, Van Dommelen P, Fekkes M, Van Wouwe JP, Amelink-Verburg MP, Verkerk PH. Cost-effectiveness of different treatment strategies with interpartum antibiotic phrophylaxis to prevent early-onset group B streptococcal disease. BJOG: an International Journal of Obstetrics and Gynecology 2005, 112:820-826.
36. Turrentine MA, Ramirez MM, Mastrobattista JM. Cost-effectiveness of universal prophylaxis in pregnancy with prior group B streptococcal colonization. Infect Dis Obstet Gynecol 2009, 2009(934698):11.
37. Kaambwa B, Bryan S, Gray J, Milner P, Daniels J, Khan KS, Roberts TE. Cost-effectiveness of rapid tests and other existing strategies for screening and management of early-onset group B streptococcus during labour. BJOG 2010, 117:1616-1627. 10.1111/j.1471-0528.2010.02752.x, 21078057.
38. Adams-Chapman I, Stoll BJ. Neonatal Infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infcet Dis 2006, 19:290-297.
39. National Insurance Institute Membership in sick funds 2004-5 2006, Jerusalem, Bendelac J, 203, http://www.btl.gov.il/publications/survey/Documents/seker_222.pdf, National Insurance Institute.
40. National Insurance Institute Membership in sick funds 2006-7 2008, Jerusalem, Bendelac J, 218, http://www.btl.gov.il/publications/survey/Documents/seker_222.pdf, National Insurance Institute.
41. National Insurance Institute Membership in sick funds 2008 2009, Jerusalem, Bendelac J, 222, http://www.btl.gov.il/publications/survey/Documents/seker_222.pdf, National Insurance Institute.
42. National Insurance Institute Membership in sick funds 2009 2010, Jerusalem, Bendelac J, 227, http://www.btl.gov.il/publications/survey/Documents/seker_227.pdf, National Insurance Institute.
43. National Insurance Institute Membership in sick funds 2010 2011, Jerusalem, Bendelac J, 233, http://www.btl.gov.il/publications/survey/Documents/seker_233.pdf, National Insurance Institute.
44. Lieu TA, Mohle-Boetami JC, Ray GT, Ackerson LM, Walton DL. For the perinatal group B streptococcal infection study group. Neonatal group B Streptococcal Infection in a Managed Care Population. Obstetet Gynecolol 1998, 92:21-27.
45. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR 2002, 51(RR11):1-22.
46. Towers CV, Rumney PJ, Asrat T, Preslicka C, Ghamsary MG, Nageotte MP. The accuracy of late third-trimester antenatal screening for group B streptococcus in predicting colonization at delivery. Am J Perinatol 2010, 27(10):785-790. 10.1055/s-0030-1254237. Epub 2010 May 10, 20458663.